All change in the UK: what is Labour's plan for pharma?

Anticipation had been building for many weeks, but when the UK’s general election finally took place on 4 July, the outcome felt entirely inevitable.

After 14 years of rule, the Conservative government performed about as badly as polls had been forecasting for months, with Labour picking up an overwhelming majority in Parliament.

Under former Prime Minister Rishi Sunak, the UK government implemented a series of policies to bolster the life sciences industry, but how will the drastic change at the top affect drugmakers and drug developers over the next five year Parliament?